Skip to content
Search

Latest Stories

RPS Scotland submits evidence to parliamentary inquiry on healthcare in remote and rural areas

RPS Scotland submits evidence to parliamentary inquiry on healthcare in remote and rural areas

Alternative training pathways vital to develop sustainable pharmacy workforce in remote and rural areas, says RPS Scotland

Royal Pharmaceutical Society (RPS) Scotland has submitted its evidence to the Health, Social Care and Sport Committee’s inquiry into ‘Healthcare in remote and rural areas.’


The Committee had sought views on what policies and actions would be most effective in addressing the issues people face when accessing healthcare in these areas.

During the evidence session today (19 December), Laura Wilson, Director for RPS Scotland, highlighted the challenges faced by pharmacists and pharmacy in remote and rural areas, as well as provided some of the solutions for ensuring a sustainable pharmacy workforce.

At present, people living in remote and rural areas of Scotland are required to travel to Glasgow or Aberdeen to undertake pharmacy training. Laura underscored the need to develop alternative education and training pathways, such as “grow your own” models, to support remote and rural areas to develop and retain local pharmacists.

Laura also made several other points, such as providing pharmacists with access to patient health records, an urgent need for pharmacy workforce planning, and a holistic approach to address cost of living and infrastructure concerns.

She said: “It is vital that we consider alternative pathways to education to ensure pharmacy is an accessible and desirable career option for people from all parts of the country.  Appropriate levels of funding should accompany this to ensure these models are viable.

“Comprehensive workforce planning for pharmacy both nationally and in remote and rural areas is a priority.  This planning should consider wider factors, including the local infrastructure such as supply of housing in remote and rural areas, to ensure pharmacists are able to live and work in these areas.

“Finally, providing pharmacists with read/write access to patient records is essential for remote and rural areas, providing patients with the ability to access care closer to home and removing the need for unnecessary travel, which is often costly and time consuming.”

The committee had sought views from anyone who uses healthcare services or works in the health and social care sector on remote and rural healthcare.

The Scottish government has committed to developing a Remote and Rural Workforce Strategy by the end of 2024 to provide a framework to support employers and fulfil the health and social care needs of people who live in remote and rural communities.

 

More For You

Imported dengue reach record high, warns UKSHA

Most dengue cases were linked to travel to Southern and South-Eastern Asia.

Getty Images

Imported dengue cases hit record high – Consult your pharmacist before you travel

The UK Health Security Agency (UKSHA) has warned that imported dengue cases in England, Wales, and Northern Ireland (EWNI) have reached their highest level since dengue surveillance began in 2009.

New data from the agency reveals that 904 dengue cases were reported among returning travellers in these countries in 2024, a sharp increase from 631 in 2023.

Keep ReadingShow less
Henry Gregg named as new NPA chief executive

Henry Gregg (left) with Sir Chris Whitty

Pic credit: Henry Gregg/X

Henry Gregg named as new NPA chief executive

The National Pharmacy Association (NPA) has announced Henry Gregg will be the organisation’s new chief executive from May.

Gregg, who is currently director of external affairs at Asthma + Lung UK, replaces Paul Rees who departed in January.

Keep ReadingShow less
Kelso Pharma continues expansion with £140M funding boost

Kelso Pharma will use the funds to support further acquisitions and expand in the UK and Europe.

Getty Images

Kelso Pharma secures over £140m of acquisition funding

Kelso Pharma has secured more than £140 million of acquisition funding to support its expansion in the UK and across Europe.

The specialty pharmaceuticals business today (27) confirmed that a proportion of the funding was used for its acquisition of ALTURiX last month, a deal that doubled the size of the company’s UK business.

Keep ReadingShow less
Community pharmacist accessing GP Connect Access Record on Cegedim Rx platform

GP Connect Access Record will make a patient’s relevant medical information available to pharmacy.

Getty Images

Cegedim Rx activates GP Connect Access Record

Community pharmacy IT supplier Cegedim Rx has made GP Connect Access Record functionality available across its clinical services platform, providing registered pharmacy professionals with enhanced access to patient medical information.

The new feature, now live on Cegedim Rx’s Pharmacy Services platform, allows community pharmacies to retrieve relevant medical data when delivering NHS clinical services.

Keep ReadingShow less
Prepayment certificates helped patients avoid £837M in prescription fees, NHSBSA analysis reveals

Patients who purchase two prescriptions per month could save more than £110 annually with a 12-month PPC.

Getty Images

Prepayment certificates helped patients avoid £837M in prescription fees, NHSBSA analysis reveals

The NHS Business Services Authority (NHSBSA) has published a new experimental analysis, estimating patient savings achieved from prescription prepayment certificates (PPCs), including Hormone Replacement Therapy (HRT) PPCs.

The report revealed that the number of Prescription Prepayment Certificates (PPCs) purchased has risen consistently over the past five years, with 3.3 million patients receiving NHS prescriptions under a PPC exemption in 2023/2024.

Keep ReadingShow less